-+ 0.00%
-+ 0.00%
-+ 0.00%

Denali Therapeutics, Royalty Pharma Enter $275 Million Royalty Funding Agreement for Hunter Syndrome Treatment

Dow Jones·12/04/2025 13:06:00

Please log in to view news